Lipocine Investor Presentation
Lipocine Inc. has updated its corporate presentation for use in meetings with investors, analysts, and other stakeholders. The presentation was filed as Exhibit 99.1 to the 8-K and provides a strategic overview of the company's business and development pipeline.